Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
Status:
Completed
Trial end date:
2020-02-24
Target enrollment:
Participant gender:
Summary
Open-label study will titrate doses of intravenous atorvastatin and monitor respective LDL-C
levels in hypercholesterolemic patients previously controlled on oral atorvastatin.